3SBio Inc. (HKG:1530)
Hong Kong · Delayed Price · Currency is HKD 23.90
0.00 (0.00%)
At close: Feb 23, 2026
3SBio Market Cap
3SBio has a market cap or net worth of 59.69 billion as of February 23, 2026. Its market cap has increased by 321.72% in one year.
Market Cap
59.69B
Enterprise Value
57.54B
Revenue
9.94B
Ranking
n/a
PE Ratio
22.75
Stock Price
23.90
Market Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 59.69B, an increase of 163.34%. That is a compound annual growth rate of 9.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 59.69B | -1.16% |
| Dec 31, 2025 | 60.39B | 321.75% |
| Dec 31, 2024 | 14.32B | -20.61% |
| Dec 29, 2023 | 18.04B | -10.89% |
| Dec 30, 2022 | 20.24B | 23.46% |
| Dec 31, 2021 | 16.40B | -8.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sino Biopharmaceutical | 118.88B |
| Akeso | 100.50B |
| Sichuan Kelun-Biotech Biopharmaceutical | 97.15B |
| RemeGen | 57.17B |
| Shanghai Henlius Biotech | 39.27B |
| Shanghai Junshi Biosciences | 35.38B |
| Biocytogen Pharmaceuticals (Beijing) | 34.58B |
| Duality Biotherapeutics | 31.46B |